The market for filter integrity test is projected to reach USD 79 million by 2024 from USD 59 million in 2018, at a CAGR of 5.0% during the forecast period. The Asia Pacific filter integrity test market, particularly in China, Japan, India, and South Korea, is expected to witness high growth in the coming years. Growth in these markets will be fueled by factors such as significant investments by key market players, increasing government support, developing R&D infrastructure, increasing outsourcing, and growing expertise and academic excellence.
Request Sample of Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=46873904
The growth of the global filter integrity test market is mainly driven by the increasing R&D spending across the globe, growth in the biopharmaceutical industry, and increasing purity requirements.
The major players in the filter integrity test market are Merck KGaA (Germany), Danaher Corporation/Pall Corporation (US), Sartorius (Germany), Donaldson Company (US), Parker Hannifin Corporation (US), Meissner Filtration Product (US), MDI Filtration Technologies (US), Thermo Fisher Scientific (US), Eaton Corporation (Ireland), and SH-Surway (China).
Sartorius is one of the leading players in the filter integrity test market. The company has a wide range of product offerings, which include filter integrity tests, transfer equipment, bottles, and bags. The company mainly focuses on product innovation and has a strong geographic presence in Europe, the Americas, and the Asia Pacific. The company is expected to grow at a positive rate in the market due to its superior product offerings.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46873904
Merck is also a prominent player in the filter integrity test market. The company has a strong geographic presence across the Americas, Europe, Asia Pacific, and the Middle East and Africa. Merck focuses on inorganic strategies to maintain its leading position in this market. For instance, in 2018, the company signed a MoU with Schneider Electric (France) to automate biopharmaceutical processes for China’s biopharmaceutical industry.
· Thermo Fisher Scientific opened the new Bioprocess Design Center in Shanghai, China to connect and collaborate with biologic developers to design bioprocessing solutions.
· Merck opened a new manufacturing and distribution center for its life science business in Mumbai, India to increase its gross domestic product storage and meet future bioproduction demand.
· Thermo Fisher Scientific acquired the Advanced Bioprocessing business from Becton, Dickinson and Company. With this acquisition, the company expanded its product portfolio of life sciences solutions.
Request for Custom Research @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=46873904